Desmopressin in Cardiac Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products. Desmopressin (DDAVP), already used for patients with von Willebrand syndrome, could reduce bleeding and transfusion requirements in these patients when administered ev (0.3 mg/kg) in 20-30 minutes postoperatively.
Epistemonikos ID: ab46920d87dd2a5ce459f9f82fb8be355d64e869
First added on: May 04, 2024